When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Edwards Lifesciences - Wikipedia

   en.wikipedia.org/wiki/Edwards_Lifesciences

   Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]

3. Transcatheter aortic valve replacement - Wikipedia

   en.wikipedia.org/wiki/Transcatheter_aortic_valve...

   Transcatheter aortic valve replacement (TAVR) is the implantation of the aortic valve of the heart through the blood vessels without actual removal of the native valve (as opposed to the aortic valve replacement by open heart surgery, surgical aortic valve replacement, AVR).

4. Artificial heart valve - Wikipedia

   en.wikipedia.org/wiki/Artificial_heart_valve

   An artificial heart valve is a one-way valve implanted into a person's heart to replace a heart valve that is not functioning properly (valvular heart disease). Artificial heart valves can be separated into three broad classes: mechanical heart valves, bioprosthetic tissue valves and engineered tissue valves.

5. Edwards Lifesciences to spin off critical care unit to focus ...

   www.aol.com/news/edwards-lifesciences-spin-off...

   The device is used to perform minimally invasive surgery for people with heart valve disease. Edwards on Thursday forecast 2024 TAVR sales in the range of $4.0 billion to $4.3 billion, compared ...

6. Aortic valve replacement - Wikipedia

   en.wikipedia.org/wiki/Aortic_valve_replacement

   Aortic valve replacement is a cardiac surgery procedure whereby a failing aortic valve is replaced with an artificial heart valve. The aortic valve may need to be replaced because of aortic regurgitation (back flow), or if the valve is narrowed by stenosis .

7. Edwards Lifesciences shares fall as slow heart-valve growth ...

   www.aol.com/news/edwards-lifesciences-shares...

   Sales of the company's Transcatheter aortic valve replacement (TAVR) device, which helps in a type of heart surgery, rose 9% to $992 million in the second quarter.